SEC Form 4 · accession 0001683168-17-002551
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wright Don
Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 2, 2017 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.80 | Sep 29, 2017 | A | 8,830 | A | — | Sep 29, 2027 | Common Stock | 8,830 | 8,830 | D |
Explanation of responses
- F1Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant: Q3 2017.